CSIMarket
 
Abbvie inc   (ABBV)
Other Ticker:  
 
 

Abbvie Inc Growth Comparisons

Select each growth Category to receive further Information



ABBV Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q4 MRQ) -5.42 % - - -
Q / Q Revenue Growth (Q4 MRQ) 2.69 % - - -
Y / Y Revenue Growth (for 12 months ending Q4 TTM) -6.44 % -15 % - %
Seq. Revenue Growth (for 12 months ending Q4 TTM) -1.49 % -10.71 % - 0.31 %
Revenue 5 Year Average Growth 10.65 % 6.79 % 7.31 % 8.35 %


ABBV's Growth Comparisons in IV. Quarter 2023




Facing -5.42% year on year sales decrease in the forth quarter 2023, to $ 14.30 billions, Abbvie Inc reported smaller declines than the Major Pharmaceutical Preparations industry with %, and less than % no change in the Healthcare sector.

Comparing the company's Revenue to the third quarter results, sales were higher by 2.69% . On the yearly basis, average annual sales growth for Abbvie Inc is 10.65%, while S & P 500's including only Businesses with the forth quarter 2023 earnings, average annual sales growth is 8.35% over the past five years.


Growth Rates of ABBV's Income in the forth quarter 2023


ABBV Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q4 MRQ) -41.93 % - - -
Seq. Operating Income Change (Q4 MRQ) 40.07 % - - -
Y / Y Operating Income Growth (Q4 TTM) -29.59 % -37.6 % -34.72 % -3.54 %
Seq. Operating Income Growth (Q4 TTM) -15.31 % -20.25 % -12.81 % -0.69 %
Operating Income 5 Year Avg. Change 14.85 % 4.16 % -0.6 % 7.74 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q4 MRQ) -66.67 % -48.15 % -20.75 % 4.22 %
Seq. Income from Cont. Ops. Change (Q4 MRQ) -53.73 % -15.88 % 42.64 % -14.69 %
Y / Y Income from Cont. Ops. Change (Q4 TTM) -58.86 % -31.28 % -26.66 % -1 %
Seq. Income from Cont. Ops. Change (Q4 TTM) -25.27 % 5.13 % 11.4 % 1.6 %
Income from Cont. Ops. 5 Year Avg. Change -3.04 % 0.23 % -4.58 % 7.52 %

ABBV Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q4 MRQ) -66.67 % -47.54 % -20.28 % -0.33 %
Q / Q Net Income Growth (Q4 MRQ) -53.73 % -72 % -49.18 % -21.73 %
Y / Y Net Income Change (Q4 TTM) -58.86 % -6.07 % -3.95 % 0.28 %
Seq. Net Income Change (Q4 TTM) -25.27 % 3.85 % 8.57 % 0.52 %
Net Income 5 Year Avg. Growth -3.04 % 6.6 % 0.52 % 7.76 %

ABBV's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q4 MRQ) -67.04 % -30.41 % -20.75 % 4.22 %
Seq. EPS from Cont. Ops. Change (Q4 MRQ) -54 % -7.95 % 42.64 % -14.69 %
Y / Y EPS from Cont. Ops. Change (Q4 TTM) -58.98 % - - -
Seq. EPS from Cont. Ops. Change (Q4 TTM) -25.52 % - - 0 %
EPS from Cont. Ops. 5 Year Avg. Growth -5.75 % -7.94 % -4.58 % 7.52 %



ABBV EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q4 MRQ) -66.54 % -29.59 % -20.28 % -0.33 %
Q / Q EPS Net Growth (Q4 MRQ) -53.53 % -69.36 % -49.18 % -21.73 %
Y / Y EPS Net Change (for 12 months ending Q4 TTM) - - - 40318.24 %
Seq. EPS Net Change (for 12 months ending Q4 TTM) -25.25 % - - 0.03 %
EPS Net 5 Year Avg. Change -5.76 % 6.6 % 0.52 % 7.76 %



As Abbvie Inc 's income per share faded by -66.54% year on year in the forth quarter, Major Pharmaceutical Preparations industry fell only by -29.59%, Abbvie Inc 's forth quarter performance was trailing Major Pharmaceutical Preparations, and underperformed the -20.28% EPS decline in the Healthcare sector. Weak forth quarter income per share, in Major Pharmaceutical Preparations industry and within the Healthcare sector, were reflected in Abbvie Inc results which underperformed overall market.

Bottom-line fell by -53.53% from the third quarter results. Comparing the annual growth, income per share of -5.76% on average in last five years, to the S & P 500's, including only Businesses with the forth quarter 2023 earnings, average yearly income per share growth is 7.76%. Abbvie Inc grew less than the market.

ABBV Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q4 MRQ) -36.01 % -21.14 % -13.64 % -9.06 %
Seq. Free Cash Flow Change (Q4 MRQ) -37.25 % -24.23 % -10.34 % -3.97 %
Y / Y Free Cash Flow Change (Q4 TTM) -8.44 % -14.72 % -10.34 % 0.99 %
Seq. Free Cash Flow Change (Q4 TTM) -10.48 % -3.3 % -2.27 % 3.16 %
Free Cash Flow 5 Year Avg. Change 11.52 % 13.55 % 9.27 % 9.84 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q4 MRQ) - 100.83 % - -
Seq. Net Cash Flow Change (Q4 MRQ) - 221.99 % - -
Y / Y Net Cash Flow Change (Q4 TTM) - - - -
Seq. Net Cash Flow Change (Q4 TTM) - 82.82 % -45.16 % -
Net Cash Flow 5 Year Avg. Change - -0.31 % 4.36 % 26.65 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q4 MRQ) -3.76 % -1.32 % -3.74 % -17.21 %
Seq. Capital Expenditures Change (Q4 MRQ) -6.39 % 9.71 % 11.03 % -0.74 %
Y / Y Capital Expenditures Change (Q4 TTM) 11.8 % 12.72 % 7.98 % 18.72 %
Seq. Capital Expenditures Change (Q4 TTM) -1.02 % 4.9 % 2.69 % 26.63 %
Capital Expenditures 5 Year Avg. Change 4.02 % 10.35 % 7.82 % 7.35 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 







Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com